Synchron
Latest round
- Series D
Last raised
- Nov 2025
Total raised
- $307M
Investors
- 33
About Synchron
Based in New York, US, Synchron, Inc. operates as a pioneering neurotechnology company, focusing on brain-computer interface solutions that enable users to control digital devices through thought, enhancing quality of life for those with limited mobility. Synchron, Inc. was founded in 2016 and is headquartered in Brooklyn, US. The company is known for its innovative approach to neurotechnology, specifically through its brain-computer interface offerings. The founders, Rahul Sharma and Thomas Oxley, have backgrounds in medical technology. In November 2025, Synchron, Inc. Synchron’s primary offering is the Chiral™, a brain-computer interface (BCI) designed to empower users to control digital devices using their thoughts. This innovative technology employs a minimally invasive endovascular procedure akin to stent placement, allowing it to bypass the need for open brain surgery. The BCI targets individuals with limited mobility due to neurological conditions, aiming to enhance autonomy and facilitate social connections. The technology is utilized in various applications, such as controlling smart home devices and navigating digital environments, thereby addressing significant challenges faced by users.Synchron's revenue model is centered around the commercialization of its Chiral™ BCI, which is positioned as an investigational device within the healthcare sector. The firm engages with healthcare providers and research institutions to facilitate clinical trials and generate interest in its technology. Revenue is derived from partnerships with hospitals and rehabilitation centers, where the BCI may be integrated into patient care programs. This model involves direct sales of the device or collaboration agreements that provide access to the technology within specific clinical settings. As the product matures and regulatory approvals are obtained, Synchron may implement subscription or service agreements to support ongoing patient use and software updates associated with the BCI.
Who invested in Synchron
33 investors across 4 rounds
See all investors in Synchron
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Synchron
Who invested in Synchron?
Synchron has 33 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synchron raised?
Synchron has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Synchron last raise money?
Synchron's most recent round on record is a Series D, in Nov 2025.
What does Synchron do?
Based in New York, US, Synchron, Inc.
Where is Synchron headquartered?
Synchron is headquartered in Brooklyn, US.
Which VCs invest in companies like Synchron?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Synchron's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Synchron? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.